Literature DB >> 7923189

Molecular determinants of dysplasia in colorectal lesions.

J Jen1, S M Powell, N Papadopoulos, K J Smith, S R Hamilton, B Vogelstein, K W Kinzler.   

Abstract

One hallmark of malignant potential is dysplasia, the disruption of normal morphology. While it is generally recognized that cancer is the result of a series of genetic changes, the relationship of these alterations and their timing to the advent of dysplasia remains obscure. To address this issue, 54 small benign colorectal lesions of various malignant potential were analyzed for APC and K-RAS mutations, two alterations which have been implicated in the early stages of colorectal tumorigenesis. APC mutations were closely associated with dysplasia. In contrast, K-RAS mutations were found to be remarkably common in small nondysplastic lesions which apparently have a limited potential to progress to larger tumors. These results provide evidence that the nature and order of genetic changes can have a specific impact on both tumor morphology (e.g., dysplasia) and the likelihood of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923189

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  107 in total

1.  Biological significance of microsatellite instability-low (MSI-L) status in colorectal tumors.

Authors:  J R Jass; J Young; B A Leggett
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 2.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

3.  Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones.

Authors:  James M Amos-Landgraf; Jarom Heijmans; Mattheus C B Wielenga; Elisa Dunkin; Kathy J Krentz; Linda Clipson; Antwan G Ederveen; Patrick G Groothuis; Sietse Mosselman; Vanesa Muncan; Daniel W Hommes; Alexandra Shedlovsky; William F Dove; Gijs R van den Brink
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

4.  Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers.

Authors:  V Y Hua; W K Wang; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Identification of dysplasia in human colonic aberrant crypt foci.

Authors:  I M Siu; T G Pretlow; S B Amini; T P Pretlow
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Topography of genetic loci in the nuclei of cells of colorectal carcinoma and adjacent tissue of colonic epithelium.

Authors:  Emilie Lukásová; Stanislav Kozubek; Martin Falk; Michal Kozubek; Jan Zaloudík; Václav Vagunda; Zdenek Pavlovský
Journal:  Chromosoma       Date:  2004-01-13       Impact factor: 4.316

Review 7.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 8.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

9.  Discovery of inhibitors of aberrant gene transcription from Libraries of DNA binding molecules: inhibition of LEF-1-mediated gene transcription and oncogenic transformation.

Authors:  James S Stover; Jin Shi; Wei Jin; Peter K Vogt; Dale L Boger
Journal:  J Am Chem Soc       Date:  2009-03-11       Impact factor: 15.419

Review 10.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.